Publication

Article

BioPharm International

Manufacturing and Facilities, November 2023 eBook
Volume2023 eBook
Issue 4
Pages: 8–13

Tech Transfer and Regulatory Compliance

Demand for efficient tech transfer, as well as compliant on-time delivery, is rising.

Performance concept of increase quality, speed, efficiency and reduce cost. Efficiency Business Concept. Business performance management and improvement concept. Cost reduction Concept. | Image Credit: © Montri - © Montri - stock.adobe.com

Montri - stock.adobe.com

Biologic manufacturing has seen numerous developments that have helped reduce production process timelines, with the industry striving to standardize and simplify manufacturing processes. By developing comprehensive strategies that include deep knowledge of the regulatory arena, specialized contract development and manufacturing organizations (CDMOs) can streamline workflows, reduce production costs, and increase efficiency. As growing numbers of biotechs seek support from expert CDMOs, efforts must be made to further streamline timelines with a sharp focus on the technology transfer process.

Read this article in BioPharm International®’s Manufacturing and Facilities 2023 eBook.

About the authors

Jinhyeok Jeong is senior director of Drug Product Inspection and Packaging, and John Thomas is senior director of Drug Product MSAT; both at Samsung Biologics.

Article details

BioPharm International
eBook: Manufacturing and Facilities 2023
November 2023
Pages: 8–13

Citation

When referring to this article, please cite it as Jeong, J.; Thomas, J. Tech Transfer and Regulatory Compliance. BioPharm International’s Manufacturing and Facilities 2023 eBook. November 2023.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
© 2025 MJH Life Sciences

All rights reserved.